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the Embryo Inside OutLineage decisions in development are thought to be primarily due to differential
activation of transcription factors. However, cell position and subcellular
organization of signalling also play a role. New studies of the Hippo pathway
in the early mouse embryo show how.Miguel Manzanares1,*
and Tristan A. Rodriguez2,*
In the early mammalian embryo, the
first cell-fate decision leads to the
formation of the trophectoderm, which
will form the placenta, and the inner cell
mass, which will give rise to the embryo
proper and yolk sac. It has long been
proposed that the position in the
embryo of the cells that will form the
trophectoderm or the inner cell mass is
key to this specification event. The
reason behind this suggestion is that
when the trophectoderm and the inner
cell mass segregate, between the 8-cell
and 16-cell stage, the embryo
resembles a compacted ball of cells
with some cells positioned on the
outside surface of this ball and others
embedded inside it. Those cells that lie
on the outside will form the
trophectoderm and are polarised with
an apical domain enriched in proteins
such as the atypical protein kinase C(aPKC) and the polarity protein Par3. By
contrast, the cells that lie inside are
apolar and will go on to form the inner
cell mass (Figure 1) [1,2]. But how is this
difference translated into the activation
of trophectoderm and inner cell mass
specific gene expression? Two new
studies in this issue of Current Biology
by the groups of Hiroshi Sasaki [3] and
Janet Rossant [4] shed important new
light on this question.
The first clue for an involvement of
the Hippo pathway in mammalian
pre-implantation development came
from analysis of mice lacking the
transcription factor Tead4 [5,6]. Tead is
a member of the Hippo pathway, a
signalling system that is evolutionarily
conserved from Drosophila
melanogaster to mammals and
controls organ size through cell
proliferation [7,8]. When the pathway is
activated, the Tead co-factors Yap and
Taz (homologues of Drosophila Yorkie)
are phosphorylated and excluded fromthe nucleus, therefore preventing
transcription of target genes. In the
blastocyst, the Tead4 protein is present
in all nuclei; however, Yap is only
localised to the nucleus of outside
trophectoderm cells. Consequently,
Tead4 mutants specify an inner cell
mass but do not form a trophectoderm
and lack proper expression of key
regulators of the trophectoderm
lineage, such as Cdx2. Therefore,
activation of the Hippo pathway
represses the trophectoderm fate. The
protein kinases Lats1/2 (homologues
of Drosophila Warts), which
phosphorylate Yap/Taz, are crucial for
this process, but again show no
differential expression between inner
and outer cells [9].
These studies provided evidence for
an involvement of the Hippo pathway
in repressing trophectoderm fate in
inside cells [9], but several important
questions remained unanswered: first
of all, it had not been established if
Hippo signalling plays any part in the
specification of the inner cell mass.
An unequivocal answer to this question
is provided by the Rossant and
Sasaki groups,whoanalysed theeffects
of loss of function of two different Hippo
pathway components that had not
previously been studied during
pre-implantation development, Nf2














Figure 1. Inner-outer patterning of the early mouse embryo by subcellular shuffling of Hippo
pathway components.
Starting at the 8-cell stage (top left), cells in the blastocyst progressively acquire inner (red) or
outer (green) character through the compacted morula (middle left) and up to the blastocyst
stages (bottom left) where the trophectoderm (TE) and inner cell mass (ICM) populations are
clearly distinct. In inner cells of the morula (right hand panel), Amot and Lats associate with
membranes though adherens junctions (green thickenings) where Nf2 is also present. In this
context, Lats can phosphorylate Amot, and subsequently this complex phosphorylates Yap
(in brown), excluding it from the nucleus. As a result, the Hippo pathway is activated (‘ON’),
resulting in an inner cell mass fate. Polarization of outer cells results in the trapping of Amot
and Lats proteins to the apical complex (red thickening) what inhibits their association and
the phosphorylation of Amot (in brown) by Lats. This configuration of the Hippo components
turns the pathway off (‘OFF’) and precludes the phosphorylation of Yap, which can then move
to the nucleus to activate the trophectoderm-specific transcriptional programme.
Current Biology Vol 23 No 13
R560and Angiomotin (Amot). Strikingly,
both the maternal/zygotic mutation
of Nf2 and the combination of
mutation of Amot and inhibition of its
paralogue, Amotl2, lead to a loss of
Hippo signalling that causes
trophectoderm markers to be
expressed in inner cell and, more
importantly, the loss of expression of
inner cell mass markers in these cells.
Furthermore, in late blastocysts from
Nf2 maternal/zygotic mutants the inner
cells also begin to take on an epithelial
character and express Cdx2, indicating
that they are truly becoming
trophectodermal. It is worth noting that
these inner cells still lack the positional
cues to establish proper apico-basal
polarity, indicating that inhibition of
Hippo signalling is likely to be
downstream of cell polarity during
trophectoderm formation.But why does Hippo signalling
become activated specifically in inner
cells if none of the components of this
pathway that have been studied so far
are restricted to outer or inner cells?
The answer we now discover, owing to
the new work by Hirate et al. [3], is that
Hippo is the read-out of the elusive
‘polarity signal’. In a very elegant series
of experiments, they provide evidence
for a direct link between the cell polarity
Par3–Par6–aPKC pathway and
repression of Hippo activity. By
disrupting Par6 or aPKC activity they
show that the establishment of polarity
is required to repress Hippo signalling
in outer cells. Furthermore, using cell
dissociation experiments, they
demonstrate that cell adhesion allows
for Hippo activation to take place in
inside cells. This provides an idea of the
cues that allow for differential Hippoactivity, but the big breakthrough of
this study is to show that Amot is the
molecular link to these cues. They find
that Amot is localised to the apical
domain of outer cells and bound to
actin where it is inactive, as it is
sequestered by components of the
polarity pathway. In contrast to this, in
inner cells, Amot is found throughout
the membrane, co-localised with
adherens junctions from where it can
mediate Hippo signalling (Figure 1).
So, if Amot is the link between the
polarity and Hippo pathways, how is
this link effected at the molecular level?
To understand this, the Sasaki lab [3]
carried out a deletion analysis of Amot
and identify the domains that mediate
interaction with adherens junctions,
actin and other Hippo pathway
components. They show that the Amot
amino terminus mediates binding to
components of the adherens junctions
and to Lats2, while its coiled-coiled
domain interacts with Nf2. This
interaction with Lats2 is key to Amot’s
function. Lats2 phosphorylates Amot
at Serine 176 and this step is required
for Amot activity and only occurs in
adherens junctions in inside cells. This
phosphorylation suppresses actin
binding, stabilises the interaction with
Lats2, Nf2 and E-cadherin, and thus
allows Amot to preferentially localise to
adherens junctions rather than to the
apical plasma membrane domain. The
question that arises from these findings
is why does Lats2 only phosphorylate
Amot in inside cells? A possible reason
can be found in the experiments by
Cockburn et al. [4]. They find that Lats2
is apically localized in outside cells but
evenly distributed throughout the
cytoplasm of inside cells, suggesting
that this protein is also sequestered,
like Amot, by components of the
polarity pathway.
Interestingly, the role of the Hippo
pathway in the early mammalian
embryo does not involve size control or
proliferation — the classical functions
ascribed to Hippo signalling. None of
the loss of function mutations of
components of the pathway studied so
far (Tead4, Nf2, Amot/Amotl2, Lats1/2)
results in changes in cell number,
arguing that during pre-implantation
development Hippo signalling has a
novel role. Furthermore, Amot proteins
have not been found in Drosophila [10],
and thus their interaction with Hippo
components would seem to be an
innovation in vertebrates. The key
novelty, however, found by these
Dispatch
R561studies [3,4] is that in the mammalian
blastocyst, the subcellular
redistribution of pathway
components results in alternative
cell fates.
What do these results tell us about
the current models for trophectoderm
and inner cell mass lineage
segregation? Historically, two
models have been put forward: the
‘inside-outside model’ suggests
a cell’s position leads to different
amounts of cell contact and different
microenvironments that are interpreted
to establish cell fate [11], while the
‘polarity model’ suggests that the
acquisition of cell polarity at the
eight-cell stage is critical for lineage
segregation [12]. The studies by the
Sasaki and Rossant labs [3,4] argue
that Hippo signalling is a sensor of both
these processes, as it is inhibited by
polarity in outside cells and activated
by cell adhesion in inside cells.
So, is everything now solved
regarding trophectoderm and inner cell
mass specification? In our minds, a key
unanswered question is if Hippo
signalling is directly controlling the
expression of lineage determinants or
if its main role is to interpret the
positional cues that the cell provides
and translate these cues for the signals
that specify fate. Yap is required to
maintain pluripotency in embryonic
stem cells [13], while in the inner cell
mass Yap is excluded from the nucleus.
Therefore, both ‘On’ and ‘Off’ states of
Hippo signalling are equally compatiblewith the pluripotent programme. Also
the main trophectoderm and inner cell
mass lineage determinants (Cdx2 and
Oct4) are initially co-expressed and
only segregate to the trophectoderm
and inner cell mass by the blastocyst
stage [14], suggesting that additional
cues to Hippo signalling are required to
restrict these genes to their specific
lineages. Understanding whether the
state of the Hippo pathway is the
only input that regulates the expression
of these trophectoderm and inner
cell mass determinants will start to
provide an answer to this fascinating
question.References
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Storage AbilityA new study demonstrates that storage organ formation can be induced in the
axillary meristem of non-tuberizing plants by ectopic expression of the
cytokinin biosynthetic gene LONELY GUY (LOG1).J.A. Abelenda and Salome´ Prat
During higher plant evolution,
vegetative organs like leaves, stems or
roots have acquired the ability to
propagate asexually, for example,
as observed in bulbs, corms, tubers
and rhizomes, and this ability provides
survival strategies during drought and
freezing conditions that compromise
plant’s viability. These undergroundstorage organs persist dormant in the
soil during adverse periods, to sprout in
the next favorable season and generate
a new plant. Metabolic storage
products accumulated in these organs,
mostly in the form of soluble sugars or
of starch, supply carbon and energy
required for initial growth of the new
shoot, hence making these organs
an excellent caloric complement to
human dietary needs. It is now widelyaccepted that early hominids fed on
these organs during fallback episodes,
and that the domestication of
tuber-bearing species most likely
preceded that of cereals and legumes.
Reiterative selection for organs of large
size gave rise to the modern potato
and cassava cultivars, potato being
nowadays the third crop in worldwide
economic importance after wheat and
rice, while cassava is one of the main
staple crops in much of tropical Africa.
Despite the enormous importance of
these storage organs, little is known
concerning how their formation is
initiated or what restricts formation of
these organs to a few plant species.
The report by Eviatar-Ribak et al.
published recently in Current Biology
[1] shows that expression of the
